Alosetron HCl 0.5 mg Oral Tablet
RxNorm 403975
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 403975 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: alosetron HCl 0.5 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Alosetron 0.5 mg Oral Tablet
(Atom ID: 1665497)
PTPrescribable
Designated preferred name (PT):
Alosetron (as alosetron hydrochloride) 500 microgram oral tablet
(Atom ID: 12664526)
SYPrescribable
Synonym (SY):
Alosetron 0.5 mg (as alosetron HCl 0.562 mg) Oral Tablet
(Atom ID: 7252786)
PSNPrescribable
Prescribable Name (PSN):
Alosetron HCl 0.5 mg Oral Tablet
(Atom ID: 7739056)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely alosetron (as alosetron hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug)
(Atom ID: 12665694)
Patient Education
Alosetron
Alosetron is used to treat diarrhea, pain, cramps, and the feeling of an urgent need to have bowel movements caused by irritable bowel syndrome (IBS; a condition that causes stomach pain, bloating, constipation, and diarrhea) in women who have diarrhea as their main symptom and have not been helped by other treatments. Alosetron is in a class of medications called 5-HT3 receptor antagonists. Alosetron works by slowing the movement of stool (bowel movements) through the intestines.
[Learn More]
* Please review the disclaimer below.